Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
151,162,791
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
15,108,904
-
Shares change
-
-260,954
-
Total reported value, excl. options
-
$250,903,236
-
Value change
-
-$6,255,939
-
Put/Call ratio
-
1.06%
-
Number of buys
-
27
-
Number of sells
-
-25
-
Price
-
$16.6
Significant Holders of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) as of Q3 2021
76 filings reported holding APLT - Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,108,904 shares
of 151,162,791 outstanding shares and own 10% of the company stock.
Largest 10 shareholders include FMR LLC (2,410,247 shares), ORBIMED ADVISORS LLC (2,257,387 shares), BlackRock Inc. (1,292,817 shares), Knoll Capital Management, LLC (1,032,123 shares), Point72 Asset Management, L.P. (1,015,271 shares), VANGUARD GROUP INC (850,299 shares), FRANKLIN RESOURCES INC (834,282 shares), Rock Springs Capital Management LP (701,680 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (639,557 shares), and ALKEON CAPITAL MANAGEMENT LLC (639,458 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.